title: Ipilimumab-associated Sweet syndrome in a melanoma patient.
authors.affiliation: Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA. Electronic address: Rachel.Gormley@uphs.upenn.edu.
authors.forename: Rachel
authors.initials: R
authors.lastname: Gormley
authors.affiliation: Department of Dermatology, University of Iowa, Carver College of Medicine, Iowa City, IA.
authors.forename: Karolyn
authors.initials: K
authors.lastname: Wanat
authors.affiliation: Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA.
authors.forename: Rosalie
authors.initials: R
authors.lastname: Elenitsas
authors.affiliation: Department of Medicine, Hematology Oncology Division, University of Pennsylvania School of Medicine, Philadelphia, PA.
authors.forename: Julia
authors.initials: J
authors.lastname: Giles
authors.affiliation: Department of Medicine, Hematology Oncology Division, University of Pennsylvania School of Medicine, Philadelphia, PA.
authors.forename: Suzanne
authors.initials: S
authors.lastname: McGettigan
authors.affiliation: Department of Medicine, Hematology Oncology Division, University of Pennsylvania School of Medicine, Philadelphia, PA.
authors.forename: Lynn
authors.initials: L
authors.lastname: Schuchter
authors.affiliation: Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA.
authors.forename: Junko
authors.initials: J
authors.lastname: Takeshita
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology; D006801:Humans; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy*; D016463:Sweet Syndrome / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab